Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (KCT0011349) titled 'Clinical research on the comparative effectiveness and safety of JHG002 therapy for chronic low back pain' on Dec. 18, 2025.
Study Type: Interventional Study
Study Design:
Primary Purpose : Treatment, Intervention Model : Parallel, Blinding/Masking : Open, Allocation : RCT
Primary Sponsor: Bucheon Jaseng Hospital of Korean Medicine, Jaseng Medical Foundation
Condition:
Diseases of the musculoskeletal system and connective tissue
Intervention:
Drug, Medical Device : JHG002 pharmacopuncture is a purified Hominis placenta extract formulated for injection at acupuncture points. In Korean medicine, Hominis placenta ...